E. Forestier

2.5k total citations
41 papers, 490 citations indexed

About

E. Forestier is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, E. Forestier has authored 41 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Infectious Diseases and 11 papers in Surgery. Recurrent topics in E. Forestier's work include Antimicrobial Resistance in Staphylococcus (9 papers), Orthopedic Infections and Treatments (7 papers) and Streptococcal Infections and Treatments (7 papers). E. Forestier is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Orthopedic Infections and Treatments (7 papers) and Streptococcal Infections and Treatments (7 papers). E. Forestier collaborates with scholars based in France, United States and Thailand. E. Forestier's co-authors include Claire Roubaud‐Baudron, T. Fraisse, G. Gavazzi, Tristan Ferry, Marc Paccalin, J. Gaillat, Léonardo Pagani, O. Lesens, Sébastien Lustıg and Cécile Batailler and has published in prestigious journals such as Kidney International, Clinical Microbiology and Infection and Age and Ageing.

In The Last Decade

E. Forestier

37 papers receiving 480 citations

Peers

E. Forestier
E. Forestier
Citations per year, relative to E. Forestier E. Forestier (= 1×) peers Anne Lotthé

Countries citing papers authored by E. Forestier

Since Specialization
Citations

This map shows the geographic impact of E. Forestier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Forestier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Forestier more than expected).

Fields of papers citing papers by E. Forestier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Forestier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Forestier. The network helps show where E. Forestier may publish in the future.

Co-authorship network of co-authors of E. Forestier

This figure shows the co-authorship network connecting the top 25 collaborators of E. Forestier. A scholar is included among the top collaborators of E. Forestier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Forestier. E. Forestier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraisse, T., Alain Putot, E. Forestier, et al.. (2025). Antibiotics at life’s end: key role in treating end-of-life pneumonia?. Expert Review of Respiratory Medicine. 19(4). 279–286.
2.
Forestier, E., G. Gavazzi, S. Diamantis, Sylvain Goutelle, & Claire Roubaud‐Baudron. (2025). Subcutaneous antibiotic therapy: Guidelines for clinical practice – Société de Pathologie Infectieuse de Langue Française/Société Française de Gériatrie et de Gérontologie. Infectious Diseases Now. 56(2). 105232–105232.
3.
Forestier, E., et al.. (2024). Seroprevalence of Infection by Borrelia Species Responsible for Lyme Disease in the French Alps: Analysis of 27,360 Serology Tests, 2015–2020. Vector-Borne and Zoonotic Diseases. 24(4). 196–200. 1 indexed citations
4.
Lesens, O., E. Forestier, Élisabeth Botelho-Nevers, et al.. (2023). Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial. European Journal of Clinical Microbiology & Infectious Diseases. 43(2). 223–232. 2 indexed citations
5.
Gavazzi, G., E. Forestier, Claire Roubaud‐Baudron, et al.. (2022). Explicit definitions of potentially inappropriate prescriptions of antibiotics in hospitalized older patients. Infectious Diseases Now. 52(4). 214–222. 3 indexed citations
6.
Forestier, E., G. Gavazzi, Tristan Ferry, et al.. (2020). Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When. Journal of the American Medical Directors Association. 22(1). 50–55.e6. 20 indexed citations
7.
Forestier, E., B. de Wazières, Louis Bernard, et al.. (2020). Determinants of doctors’ antibiotic prescriptions for patients over 75 years old in the terminal stage of palliative care. Infectious Diseases Now. 51(4). 340–345. 9 indexed citations
8.
Valour, Florent, et al.. (2019). Subcutaneous teicoplanin in staphylococcal bone and joint infections. Médecine et Maladies Infectieuses. 50(1). 83–86. 6 indexed citations
9.
Forestier, E., et al.. (2018). Cheminement diagnostique et vécu des patients se pensant atteints de « maladie de Lyme chronique ». La Revue de Médecine Interne. 39(12). 912–917. 10 indexed citations
10.
Lesens, O., Tristan Ferry, E. Forestier, et al.. (2018). Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study. European Journal of Clinical Microbiology & Infectious Diseases. 37(10). 1949–1956. 23 indexed citations
11.
Forestier, E., Matthieu Roustit, Sandrine Boisset, et al.. (2017). Assessment of linezolid prescriptions in three French hospitals. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1133–1141. 5 indexed citations
12.
Lemaire, X., É. Bonnet, Bernard Castan, et al.. (2016). Management of non-necrotizing cellulitis in France. Médecine et Maladies Infectieuses. 46(7). 355–359. 4 indexed citations
13.
Roubaud‐Baudron, Claire, E. Forestier, T. Fraisse, et al.. (2016). Tolerance of subcutaneously administered antibiotics: a French national prospective study. Age and Ageing. 46(1). 151–155. 29 indexed citations
14.
Boibieux, A., C. Ploton, Tristan Ferry, et al.. (2016). Keep an Ear Out for Francisella tularensis: Otomastoiditis Cases after Canyoneering. Frontiers in Medicine. 3. 9–9. 13 indexed citations
15.
Forestier, E., Marc Paccalin, Claire Roubaud‐Baudron, et al.. (2014). Subcutaneously administered antibiotics: a national survey of current practice from the French Infectious Diseases (SPILF) and Geriatric Medicine (SFGG) society networks. Clinical Microbiology and Infection. 21(4). 370.e1–370.e3. 38 indexed citations
16.
Fraisse, T., Marc Paccalin, Virginie Vitrat, et al.. (2014). Aminoglycosides use in patients over 75 years old. Age and Ageing. 43(5). 676–681. 18 indexed citations
17.
Forestier, E., et al.. (2012). Ertapénem intraveineux ou sous-cutané pour le traitement des infections urinaires à entérobactérie sécrétrice de BLSE. Médecine et Maladies Infectieuses. 42(9). 440–443. 21 indexed citations
18.
Forestier, E.. (2009). Stratégie de prise en charge (diagnostic, surveillance, suivi) d’une méningite aiguë communautaire présumée bactérienne de l’adulte. Médecine et Maladies Infectieuses. 39(7-8). 606–614. 1 indexed citations
19.
Lefèbvre, Nicolas, E. Forestier, David Farhi, et al.. (2007). Minocycline-induced hypersensitivity syndrome presenting with meningitis and brain edema: a case report. Journal of Medical Case Reports. 1(1). 22–22. 10 indexed citations
20.
Lefèbvre, Nicolas, E. Forestier, Véronique Rémy, et al.. (2007). Les infections invasives à Streptococcus agalactiae chez l'adulte (femme enceinte exclue). Médecine et Maladies Infectieuses. 37(12). 796–801. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026